Plaque Psoriasis Market will reach USD 47.24 billion in 2029,Opportunities Analysis

Plaque psoriasis is the most basic form of psoriasis and accounts for 80% to 90% cases of total psoriasis. Plaque psoriasis is an autoimmune condition, in which thick, red patches appear on the skin. These plaques generally appear on the knees, scalp, and elbows. however, these can also appear on other body part. These are itchy, painful, and can bleed. The exact cause of plaque psoriasis is still unknown.

View Detailed Report : https://www.databridgemarketresearch.com/reports/global-plaque-psoriasis-market

Plaque psoriasis is the most basic form of psoriasis, accounting for 80 to 90 percent of total psoriasis cases. Plaque psoriasis is an autoimmune condition characterized by thick, red patches on the skin. These plaques are most commonly found on the knees, scalp, and elbows. However, these can also appear on other parts of the body. These are itchy, painful, and have the potential to bleed. The precise cause of plaque psoriasis is unknown.

The plaque psoriasis is supportive and aims to reduce the severity of the symptoms. Data Bridge Market Research analyses that the plaque psoriasis market will grow at a CAGR of 6.50% during the forecast period of 2022 to 2029. The market value, which was USD 26.37 billion in 2021 will reach USD 47.24 billion in 2029. The growing demand for better healthcare infrastructure is driving the plaque psoriasis market forward.

Some of the major players operating in the plaque psoriasis market are

Pfizer Inc. (US)

GlaxoSmithKline plc (UK)

Novartis AG (Switzerland)

Mylan N.V. (US)

Teva Pharmaceutical Industries Ltd.(Israel)

Sanofi (France)

Boehringer Ingelheim International GmbH. (Germany)

AstraZeneca (UK)

Johnson & Johnson Private Limited (US)

Bayer AG (Germany)

Merck & Co., Inc. (US)

F. Hoffmann-La Roche Ltd. (Switzerland)

Bristol-Myers Squibb Company (US)

Cadila Pharmaceuticals (India)

Eli Lilly and Company (US)

LEO Pharma A/S (Denmark)

Cipla Inc. (US)

Aurobindo Pharma (India)

Lupin (India)

Sumitomo Corporation (Japan)

Drivers

Rise in psoriasis prevalence

The rise in psoriasis prevalence and a rich promising pipeline of drugs are expected to drive growth in the plaque psoriasis market during the forecast period.

Increasing investment for healthcare infrastructure

The change in lifestyle is expected to fuel the growth of the plaque psoriasis market. Furthermore, an increase in treatment awareness is expected to cushion the growth of the plaque psoriasis market

Global Plaque Psoriasis Market Scope

The plaque psoriasis market is segmented on the basis of treatment, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

Topical therapy

Phototherapy

Systemic agents

Biologic therapies

Others

Explore More Reports:

https://dbmrresearchreports.blogspot.com/2024/04/queen-mattress-market-growing-at-growth.html

https://dbmrresearchreports.blogspot.com/2024/04/nutritional-beverages-market-to-reach_2.html

https://dbmrresearchreports.blogspot.com/2024/04/vegan-ice-cream-market-to-undergo-cagr_2.html

https://dbmrresearchreports.blogspot.com/2024/04/ready-to-drink-rtd-beverages-market-to_2.html

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact Us:

Data Bridge Market Research
Tel: +1-888-389.80-2818 | +44 208 089 1725 | +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

This release was published on openPR.